Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants

DOI PDF 9 Citations
  • Stella M. Davies
    From the Blood and Marrow Transplant Program, University of Minnesota, Minneapolis; and Department of Clinical and Experimental Medicine, Division of Hematology and Clinical Immunology, Perugia University School of Medicine, Perugia, Italy.
  • Loredana Ruggieri
    From the Blood and Marrow Transplant Program, University of Minnesota, Minneapolis; and Department of Clinical and Experimental Medicine, Division of Hematology and Clinical Immunology, Perugia University School of Medicine, Perugia, Italy.
  • Todd DeFor
    From the Blood and Marrow Transplant Program, University of Minnesota, Minneapolis; and Department of Clinical and Experimental Medicine, Division of Hematology and Clinical Immunology, Perugia University School of Medicine, Perugia, Italy.
  • John E. Wagner
    From the Blood and Marrow Transplant Program, University of Minnesota, Minneapolis; and Department of Clinical and Experimental Medicine, Division of Hematology and Clinical Immunology, Perugia University School of Medicine, Perugia, Italy.
  • Daniel J. Weisdorf
    From the Blood and Marrow Transplant Program, University of Minnesota, Minneapolis; and Department of Clinical and Experimental Medicine, Division of Hematology and Clinical Immunology, Perugia University School of Medicine, Perugia, Italy.
  • Jeffrey S. Miller
    From the Blood and Marrow Transplant Program, University of Minnesota, Minneapolis; and Department of Clinical and Experimental Medicine, Division of Hematology and Clinical Immunology, Perugia University School of Medicine, Perugia, Italy.
  • Andrea Velardi
    From the Blood and Marrow Transplant Program, University of Minnesota, Minneapolis; and Department of Clinical and Experimental Medicine, Division of Hematology and Clinical Immunology, Perugia University School of Medicine, Perugia, Italy.
  • Bruce R. Blazar
    From the Blood and Marrow Transplant Program, University of Minnesota, Minneapolis; and Department of Clinical and Experimental Medicine, Division of Hematology and Clinical Immunology, Perugia University School of Medicine, Perugia, Italy.

Abstract

<jats:p>One of the functions of HLA class I alleles is interaction with natural killer (NK) cells. Receptors termed killer immunoglobulinlike receptors (KIRs) on NK cells recognize groups of HLA class I alleles, and interaction between receptor and class I allele inhibits reactivity of the NK cell. Failure to recognize the appropriate KIR ligand on a mismatched cell can trigger NK cell elimination of that target cell. Recent analysis of haploidentical hematopoietic transplantations has shown a reduction of graft failure, graft-versus-host disease, and relapse in those with KIR ligand incompatibility in the graft-versus-host direction. In this study we analyzed the effect of KIR ligand incompatibility on outcomes of unrelated donor bone marrow transplantations. The data show no advantage for KIR ligand incompatibility in this clinical setting as assessed by HLA-Bw4 and HLA-C alleles. It is possible that there will be a benefit of NK cell alloreactivity if strategies of haploidentical transplantation are used: high stem cell doses, extensive T-cell depletion, and no postgrafting immune suppression.</jats:p>

Journal

  • Blood

    Blood 100 (10), 3825-3827, 2002-11-15

    American Society of Hematology

Citations (9)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top